Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by Tiziana Life Sciences Ltd.

< Previous 1 2 3 4 Next >
News headline image
Tiziana Life Sciences Announces Closing of Oversubscribed $8.8 Million Registered Direct Offering of Ordinary Shares
From Tiziana Life Sciences Ltd.
Via GlobeNewswire
Tickers TLSA
News headline image
Tiziana Life Sciences Announces Registered Direct Offering of up to approximately $17.6 Million
From Tiziana Life Sciences Ltd.
Via GlobeNewswire
Tickers TLSA
News headline image
Tiziana Life Sciences to Present at the 9th Annual Neuroscience Innovation Forum During J.P. Morgan Healthcare Conference Week in San Francisco
From Tiziana Life Sciences Ltd.
Via GlobeNewswire
Tickers TLSA
News headline image
Tiziana Files Annual Safety Report for Intranasal Foralumab with FDA
From Tiziana Life Sciences Ltd.
Via GlobeNewswire
Tickers TLSA
News headline image
Tiziana Life Sciences Announces Acquisition of Shares by Executive Chairman
From Tiziana Life Sciences Ltd.
Via GlobeNewswire
Tickers TLSA
News headline image
Tiziana Life Sciences to Ring the Closing Bell at Nasdaq
From Tiziana Life Sciences Ltd.
Via GlobeNewswire
Tickers TLSA
News headline image
Tiziana Life Sciences Doses First Patient in Phase 2 Alzheimer’s Clinical Trial
From Tiziana Life Sciences Ltd.
Via GlobeNewswire
Tickers TLSA
News headline image
Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officer
From Tiziana Life Sciences Ltd.
Via GlobeNewswire
Tickers TLSA
News headline image
Tiziana Life Sciences Announces Withdrawal of Proposed Public Offering
From Tiziana Life Sciences Ltd.
Via GlobeNewswire
Tickers TLSA
News headline image
Tiziana Life Sciences to Dose First Patient in Phase 2 Alzheimer’s Trial
From Tiziana Life Sciences Ltd.
Via GlobeNewswire
Tickers TLSA
News headline image
Tiziana Life Sciences Plans to Spinout IL-6 Asset into Separate Listed Company
From Tiziana Life Sciences Ltd.
Via GlobeNewswire
Tickers TLSA
News headline image
Tiziana Life Sciences Nasal Foralumab Phase 2 Clinical Trial Accepted into Healey ALS MyMatch Program
From Tiziana Life Sciences Ltd.
Via GlobeNewswire
Tickers TLSA
News headline image
Tiziana Life Sciences to Present at Jefferies Global Healthcare Conference
From Tiziana Life Sciences Ltd.
Via GlobeNewswire
Tickers TLSA
News headline image
Tiziana Life Sciences to Present at BIO-Europe in Vienna, Highlighting Innovative Immunomodulation Therapy
From Tiziana Life Sciences Ltd.
Via GlobeNewswire
Tickers TLSA
News headline image
Tiziana Life Sciences Invited to Attend Life Sciences Innovation Forum 2025 in Riyadh, Saudi Arabia
From Tiziana Life Sciences Ltd.
Via GlobeNewswire
Tickers TLSA
News headline image
Tiziana to Advance TZLS-501 - Its Fully Human IL-6R Monoclonal Antibody
From Tiziana Life Sciences Ltd.
Via GlobeNewswire
Tickers TLSA
News headline image
Tiziana Life Sciences Announces Poster Presentation on Intranasal Foralumab Clinical Trial at the 41st ECTRIMS Congress
From Tiziana Life Sciences Ltd.
Via GlobeNewswire
Tickers TLSA
News headline image
Department of Defense Awards Grant to Advance Tiziana Life Sciences Intranasal Anti-CD3 Therapy for Spinal Cord Injury
From Tiziana Life Sciences Ltd.
Via GlobeNewswire
Tickers TLSA
News headline image
Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officer
From Tiziana Life Sciences Ltd.
Via GlobeNewswire
Tickers TLSA
News headline image
Tiziana Life Sciences Announces Purchase of Shares by Chairman
From Tiziana Life Sciences Ltd.
Via GlobeNewswire
Tickers TLSA
News headline image
Tiziana Life Sciences Doses First Patient in Phase 2a Trial of Intranasal Foralumab for Multiple System Atrophy
From Tiziana Life Sciences Ltd.
Via GlobeNewswire
Tickers TLSA
News headline image
FDA Approves Tiziana Life Sciences Phase 2 IND for Multiple System Atrophy
From Tiziana Life Sciences Ltd.
Via GlobeNewswire
Tickers TLSA
News headline image
Tiziana Life Sciences Announces Immunologic Analysis of Nasal Foralumab in Moderate Alzheimer's Patient
From Tiziana Life Sciences Ltd.
Via GlobeNewswire
Tickers TLSA
News headline image
Tiziana Life Sciences Expands Phase 2 Clinical Trial of Intranasal Foralumab with Commencement of First Patient Dosing at Weill Cornell Multiple Sclerosis Center
From Tiziana Life Sciences Ltd.
Via GlobeNewswire
Tickers TLSA
News headline image
Tiziana Life Sciences to Present at the Bio International Convention
From Tiziana Life Sciences Ltd.
Via GlobeNewswire
Tickers TLSA
News headline image
Tiziana Life Sciences Announces Interview Highlighting Intranasal Foralumab for the Treatment of Moderate Alzheimer’s Disease
From Tiziana Life Sciences Ltd.
Via GlobeNewswire
Tickers TLSA
News headline image
Journal of Clinical Nuclear Medicine Publishes Results of Tiziana’s Nasal Foralumab in Study Treating Moderate Alzheimer's Disease
From Tiziana Life Sciences Ltd.
Via GlobeNewswire
Tickers TLSA
News headline image
Tiziana Life Sciences Announces Purchase of Shares by Chairman
From Tiziana Life Sciences Ltd.
Via GlobeNewswire
Tickers TLSA
News headline image
Tiziana Life Sciences Announces Significant Reduction in Microglia Activation in PET Scan of Moderate Alzheimer's Patient Treated with Intranasal Foralumab
From Tiziana Life Sciences Ltd.
Via GlobeNewswire
Tickers TLSA
News headline image
Tiziana Life Sciences Announces Comprehensive Positive Results from Study of Nasal Foralumab in Patients with Multiple Sclerosis
From Tiziana Life Sciences Ltd.
Via GlobeNewswire
Tickers TLSA
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.